<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene T19R;G142D	;E156del;F157del;R158G;L452R;T478K;D614G;P681R;D950N literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.T19R;G142D	;E156_F157del;R158G;L452R;T478K;D614G;P681R;D950N</span> literature reference collection</h1>
<div class="effect_section"><h2 id="antibody_epitope_effects">Antibody epitope effects</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> BnAb 002-S21F2 IC50 on the Delta (B.1.617.2) variant is 0.6x fold the wildtype.<br/> (<a href="https://doi.org/10.1101/2022.05.13.491770" class="lit_link">Kumar et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Neutralization of the bsAbs Bi-Nab35B5-47D10. Delta (B.1.617.2) has an IC50 fold change of 0.57x.<br/> (<a href="https://doi.org/10.1101/2022.05.11.491588" class="lit_link">Yuan et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Neutralization of the bsAbs Bi-Nab47D10-35B5. Delta (B.1.617.2) has an IC50 fold change of 0.15x.<br/> (<a href="https://doi.org/10.1101/2022.05.11.491588" class="lit_link">Yuan et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Neutralization of the bsAbs 35B5. Delta (B.1.617.2) has an IC50 fold change of 0.87x.<br/> (<a href="https://doi.org/10.1101/2022.05.11.491588" class="lit_link">Yuan et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Neutralization of the bsAbs 47D10. Delta (B.1.617.2) has an IC50 fold change of 46.5x.<br/> (<a href="https://doi.org/10.1101/2022.05.11.491588" class="lit_link">Yuan et al. (2022)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
